PEOPLE - Theragenics (US) makes appointment:
This article was originally published in Clinica
Theragenics (Buford, Georgia), the manufacturer of TheraSeed, a device used in the treatment of localised prostate cancer, has appointed James Maclennan as CFO and treasurer. Mr Maclennan most recently served as executive vice-president and CFO of technical products and digital solutions company Lanier Worldwide. It has also promoted Bruce Smith to the position of vice-president of strategy, development and acquisitions. Mr Smith, who has served Theragenics for 15 years, most recently served as CFO - a position he held for 13 years.
You may also be interested in...
A recent Department of Health and Human Services proposal to review regulations every 10 years may mean good things for the device industry, said David Hoffmeister, partner, Wilson Sonsini Goodrich & Rosati.
Aker BioMarine seeks supplement firms to use its EPA/DHA innovation bound by lysophosphatidylcholine to enable the fatty acids to pass through the blood-brain and blood-retinal barriers and boost of eye and brain health benefits. It will submit an NDI notificaion in the US during 2022.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.